Lucas Nivon is the founder of Cyrus Biotechnology. Cyrus Biotechnology has raised $8M in total funding. Latest round: Series A.
Lucas Nivon is the CEO of Cyrus Biotechnology, a Seattle-based biotechnology software firm. The company offers Cyrus Bench®, an advanced computational tool for protein modeling and design that aims to accelerate new drug discovery. Cyrus Biotechnology secured an $8 million Series A financing round in 2017 to expand its computational drug discovery software platform.
Full founder directory · Investor directory · Company funding database · Fundraising library